Virological course of herpes zoster in otherwise normal hosts

References

1. Arvin A. M., Koropchak C. M. 1980; Immunoglobulin M and immunoglobulin G to Varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. Journal of Clinical Microbiology 12:367–374
   [Google Scholar]
2. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. 1974; Herpes virus varicellae isolated from human dorsal root ganglia. Archives of Pathology 97:331–333
   [Google Scholar]
3. Cevenini R., Donati M., Rumpianesi F. 1981; Elementary bodies as single-antigen in a micro-ELISA test for Chlamydia trachomatis antibodies. Microbiologica 4:347–351
   [Google Scholar]
4. Gerna G., Cereda P. M., Cattaneo E., Achilli G., Gerna M. T. 1979; Antibody to early antigens of Varicella-zoster virus during varicella and zoster. Journal of Infectious Diseases 140:33–41
   [Google Scholar]
5. Gold E. 1966; Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. New England Journal of Medicine 274:181–185
   [Google Scholar]
6. Hacham M., Leventon-Kriss S., Sarov I. 1980; Enzyme-linked immunosorbent assay for detection of virus-specific IgM antibodies to Varicella-zoster virus. Intervirology 13:214–222
   [Google Scholar]
7. Haikin H., Leventon-Kriss S., Sarov I. 1979; Antibody to Varicella-zoster virus-induced membrane antigen: immunoperoxidase assay with air-dried target cells. Journal of Infectious Diseases 140:601–604
   [Google Scholar]
8. Johnson M. T., Luby J. P., Buchanan R. A., Mikulec D. 1975; Treatment of Varicella-zoster virus infections with adenine arabinoside. Journal of Infectious Diseases 131:225–229
   [Google Scholar]
9. Johnson R. B., Libby R. 1980; Separation of immunoglobulin M (IgM) essentially free of IgG from serum for use in systems requiring assay of IgM-type antibodies without interference from rheumatoid factor. Journal of Clinical Microbiology 12:451–454
   [Google Scholar]
10. Joncas J. H. 1979; Persistence, reactivation and cell transformation by human herpes viruses: Herpes simplex, 1, 2 (HSV-1, HSV-2), Cytomegalovirus (CMV), Varicella-zoster (VZV), Epstein-Barr virus (EBV). Canadian Journal of Microbiology 25:254–260
    [Google Scholar]
11. Leventon-Kriss S., Yoffe R., Rannon L., Modan M. 1978; Seroepidemiologic aspects of Varicella-zoster virus infections in an Israeli Jewish population. Israel Journal of Medical Sciences 14:766–770
    [Google Scholar]
12. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
13. Nikoskelainen J., Hanninen P. 1975; Antibody response to Epstein-Barr virus in infectious mononucleosis. Infection and Immunity 11:42–51
    [Google Scholar]
14. Ross C. A. C., McDaid R. 1972; Specific IgM antibody in serum of patients with herpes zoster infections. British Medical Journal 4:522–523
    [Google Scholar]
15. Schimpff S., Serpick A., Stoler B., Rumack H., Mellin J. M., Block J. 1972; Varicella-zoster infection in patients with cancer. Annals of Internal Medicine 76:241–254
    [Google Scholar]
16. Schmidt N. J., Lennette E. H. 1975; Neutralizing antibody responses to Varicella-zoster virus. Infection and Immunity 12:606–613
    [Google Scholar]
17. Shirodaria P. V., Fraser K. B., Stanford F. 1973; Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti IgM. Annals of the Rheumatic Diseases 32:53–57
    [Google Scholar]
18. Tedder R.S., Mortimer P. P., Lord R. B. 1981; Detection of antibody to Varicella-zoster virus by competitive and IgM-antibody capture immunoassay. Journal of Medical Virology 8:89–101
    [Google Scholar]
19. Whitley R. J., Ch’ien L. T., Dolin R., Galasso G. J., Alford C. A. The Collaborative Study Group 1976; Adenine arabinoside therapy of herpes zoster in immunosuppressed. NIAID collaborative antiviral study. New England Journal of Medicine 294:1193–1199
    [Google Scholar]
20. Williams V., Gershon A., Brunell P. A. 1974; Serologic response to Varicella-zoster membrane antigens measured by indirect immunofluorescence. Journal of Infectious Diseases 130:669–672
    [Google Scholar]